Key facts
- This page summarizes CS Interpharm General Trading Co. LLC's Form 3 filing for CS DIAGNOSTICS CORP. (CSDX).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 04 Feb 2026, 14:00.
CS Interpharm General Trading Co. LLC - 31 Dec 2025 Form 3 Insider Report for CS DIAGNOSTICS CORP. (CSDX)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- CSDX
- Reported as of
- 31 Dec 2025
- Net transaction value
- $0
- Reporting owner signature
- /s/ Mohammad Essayed
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
CS Interpharm General Trading Co. LLC filed Form 3 for CS DIAGNOSTICS CORP. (CSDX) on 04 Feb 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002106403
Primary reporting owner
CS Interpharm General Trading Co. LLC
- Relationship
- 10%+ Owner
- Address
- 1603 CAPITOL AVENUE, SUITE 413, CHEYENNE
- Signature
- /s/ Mohammad Essayed
- Signature date
- 04 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CSDX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 42,560,096
- Date
- 31 Dec 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.